Predictive Oncology (POAI), a biotechnology company specializing in AI-driven cancer research, has announced a $344.4 million digital asset treasury centered...
Predictive Oncology (POAI), a biotechnology company specializing in AI-driven cancer research, has announced a $344.4 million digital asset treasury centered...
The company accepted Bitcoin and SolvBTC from investors in a private share deal, adding crypto assets to its corporate treasury....
